Logo image of ALSOG.PA

SOGECLAIR (ALSOG.PA) Stock Fundamental Analysis

EPA:ALSOG - Euronext Paris - Matif - FR0000065864 - Common Stock - Currency: EUR

23.2  0 (0%)

Fundamental Rating

4

ALSOG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 38 industry peers in the Aerospace & Defense industry. While ALSOG seems to be doing ok healthwise, there are quite some concerns on its profitability. ALSOG is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALSOG had positive earnings in the past year.
ALSOG had a positive operating cash flow in the past year.
ALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 10M -10M 20M

1.2 Ratios

ALSOG has a worse Return On Assets (1.90%) than 65.79% of its industry peers.
With a Return On Equity value of 6.40%, ALSOG is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
ALSOG has a Return On Invested Capital (5.54%) which is comparable to the rest of the industry.
ALSOG had an Average Return On Invested Capital over the past 3 years of 4.53%. This is below the industry average of 8.78%.
The 3 year average ROIC (4.53%) for ALSOG is below the current ROIC(5.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.9%
ROE 6.4%
ROIC 5.54%
ROA(3y)1.69%
ROA(5y)N/A
ROE(3y)5.31%
ROE(5y)N/A
ROIC(3y)4.53%
ROIC(5y)N/A
ALSOG.PA Yearly ROA, ROE, ROICALSOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

The Profit Margin of ALSOG (1.84%) is worse than 68.42% of its industry peers.
ALSOG has a Operating Margin of 4.00%. This is in the lower half of the industry: ALSOG underperforms 65.79% of its industry peers.
ALSOG has a Gross Margin of 54.60%. This is amongst the best in the industry. ALSOG outperforms 86.84% of its industry peers.
ALSOG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4%
PM (TTM) 1.84%
GM 54.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5YN/A
ALSOG.PA Yearly Profit, Operating, Gross MarginsALSOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALSOG is destroying value.
The number of shares outstanding for ALSOG has been reduced compared to 1 year ago.
The debt/assets ratio for ALSOG is higher compared to a year ago.
ALSOG.PA Yearly Shares OutstandingALSOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 1M 2M 3M
ALSOG.PA Yearly Total Debt VS Total AssetsALSOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.22 indicates that ALSOG is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALSOG's Altman-Z score of 2.22 is in line compared to the rest of the industry. ALSOG outperforms 50.00% of its industry peers.
The Debt to FCF ratio of ALSOG is 9.11, which is on the high side as it means it would take ALSOG, 9.11 years of fcf income to pay off all of its debts.
ALSOG's Debt to FCF ratio of 9.11 is on the low side compared to the rest of the industry. ALSOG is outperformed by 60.53% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that ALSOG is somewhat dependend on debt financing.
ALSOG has a Debt to Equity ratio of 0.53. This is in the better half of the industry: ALSOG outperforms 68.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 9.11
Altman-Z 2.22
ROIC/WACC0.71
WACC7.83%
ALSOG.PA Yearly LT Debt VS Equity VS FCFALSOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 10M 20M 30M 40M

2.3 Liquidity

ALSOG has a Current Ratio of 1.59. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
ALSOG's Current ratio of 1.59 is amongst the best of the industry. ALSOG outperforms 89.47% of its industry peers.
ALSOG has a Quick Ratio of 1.36. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.36, ALSOG belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.36
ALSOG.PA Yearly Current Assets VS Current LiabilitesALSOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.15% over the past year.
Looking at the last year, ALSOG shows a quite strong growth in Revenue. The Revenue has grown by 10.45% in the last year.
The Revenue has been growing slightly by 6.36% on average over the past years.
EPS 1Y (TTM)27.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.76%
Revenue 1Y (TTM)10.45%
Revenue growth 3Y6.36%
Revenue growth 5YN/A
Sales Q2Q%9.01%

3.2 Future

The Earnings Per Share is expected to grow by 28.06% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.66% on average over the next years.
EPS Next Y46.67%
EPS Next 2Y36.32%
EPS Next 3Y28.06%
EPS Next 5YN/A
Revenue Next Year6.76%
Revenue Next 2Y7.18%
Revenue Next 3Y6.66%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALSOG.PA Yearly Revenue VS EstimatesALSOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
ALSOG.PA Yearly EPS VS EstimatesALSOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.68, which indicates a rather expensive current valuation of ALSOG.
ALSOG's Price/Earnings ratio is a bit cheaper when compared to the industry. ALSOG is cheaper than 76.32% of the companies in the same industry.
ALSOG is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 10.10, which indicates a very decent valuation of ALSOG.
Based on the Price/Forward Earnings ratio, ALSOG is valued cheaper than 100.00% of the companies in the same industry.
ALSOG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 24.68
Fwd PE 10.1
ALSOG.PA Price Earnings VS Forward Price EarningsALSOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALSOG is valued cheaply inside the industry as 97.37% of the companies are valued more expensively.
ALSOG's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALSOG is cheaper than 89.47% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.35
EV/EBITDA 6.49
ALSOG.PA Per share dataALSOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

ALSOG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALSOG's earnings are expected to grow with 28.06% in the coming years.
PEG (NY)0.53
PEG (5Y)N/A
EPS Next 2Y36.32%
EPS Next 3Y28.06%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.05%, ALSOG is a good candidate for dividend investing.
ALSOG's Dividend Yield is rather good when compared to the industry average which is at 1.22. ALSOG pays more dividend than 100.00% of the companies in the same industry.
ALSOG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 4.05%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALSOG.PA Yearly Dividends per shareALSOG.PA Yearly Dividends per shareYearly Dividends per share 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

100.39% of the earnings are spent on dividend by ALSOG. This is not a sustainable payout ratio.
DP100.39%
EPS Next 2Y36.32%
EPS Next 3Y28.06%
ALSOG.PA Yearly Income VS Free CF VS DividendALSOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 0 10M -10M 20M
ALSOG.PA Dividend Payout.ALSOG.PA Dividend Payout, showing the Payout Ratio.ALSOG.PA Dividend Payout.PayoutRetained Earnings

SOGECLAIR

EPA:ALSOG (3/7/2025, 7:00:00 PM)

23.2

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)10-30 2024-10-30
Earnings (Next)03-12 2025-03-12/amc
Inst Owners4.62%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap74.24M
Analysts86.67
Price Target28.05 (20.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.05%
Yearly Dividend0.9
Dividend Growth(5Y)N/A
DP100.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 24.68
Fwd PE 10.1
P/S 0.48
P/FCF 20.35
P/OCF 13.98
P/B 1.67
P/tB 3.38
EV/EBITDA 6.49
EPS(TTM)0.94
EY4.05%
EPS(NY)2.3
Fwd EY9.9%
FCF(TTM)1.14
FCFY4.92%
OCF(TTM)1.66
OCFY7.15%
SpS48.31
BVpS13.92
TBVpS6.86
PEG (NY)0.53
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.9%
ROE 6.4%
ROCE 7.4%
ROIC 5.54%
ROICexc 6.28%
ROICexgc 8.98%
OM 4%
PM (TTM) 1.84%
GM 54.6%
FCFM 2.36%
ROA(3y)1.69%
ROA(5y)N/A
ROE(3y)5.31%
ROE(5y)N/A
ROIC(3y)4.53%
ROIC(5y)N/A
ROICexc(3y)5.98%
ROICexc(5y)N/A
ROICexgc(3y)9.11%
ROICexgc(5y)N/A
ROCE(3y)6.07%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5YN/A
F-Score6
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 9.11
Debt/EBITDA 1.59
Cap/Depr 19.34%
Cap/Sales 1.08%
Interest Coverage 4.66
Cash Conversion 35.94%
Profit Quality 127.99%
Current Ratio 1.59
Quick Ratio 1.36
Altman-Z 2.22
F-Score6
WACC7.83%
ROIC/WACC0.71
Cap/Depr(3y)356.47%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.93%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.76%
EPS Next Y46.67%
EPS Next 2Y36.32%
EPS Next 3Y28.06%
EPS Next 5YN/A
Revenue 1Y (TTM)10.45%
Revenue growth 3Y6.36%
Revenue growth 5YN/A
Sales Q2Q%9.01%
Revenue Next Year6.76%
Revenue Next 2Y7.18%
Revenue Next 3Y6.66%
Revenue Next 5YN/A
EBIT growth 1Y-3.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year167.19%
EBIT Next 3Y49.59%
EBIT Next 5YN/A
FCF growth 1Y283.71%
FCF growth 3Y-43.63%
FCF growth 5YN/A
OCF growth 1Y75.43%
OCF growth 3Y-39.89%
OCF growth 5YN/A